Brief: Titan Pharmaceuticals Announces Board Expansion And Management Changes
16/08/2022 18:50
Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES BOARD EXPANSION AND
MANAGEMENT
CHANGES
* TITAN PHARMACEUTICALS INC - HAS EXPANDED ITS BOARD OF
DIRECTORS
FROM FIVE TO ELEVEN
* TITAN PHARMACEUTICALS INC - APPOINTED SIX NEW DIRECTORS
FOLLOWING THEIR ELECTION AT ITS SPECIAL MEETING OF STOCKHOLDERS
HELD ON AUGUST 15
* TITAN PHARMACEUTICALS INC - IN ADDITION, FOLLOWING
SPECIAL
MEETING, DAVID E. LAZAR WAS APPOINTED INTERIM CHAIRMAN AND CHIEF
EXECUTIVE OFFICER
* TITAN PHARMACEUTICALS INC - LAZAR SUCCEEDS MARC RUBIN, WHO
WILL
NO LONGER SERVE AS EXECUTIVE CHAIRMAN, BUT WILL REMAIN ON BOARD
Source text for Eikon: ID:nPnn7Gvca
Further company coverage: TTNP.O
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.